SALBUTAMOL SULFATE

( DrugBank: Salbutamol / KEGG DRUG: Albuterol )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
111	先天性ミオパチー	2

111. 先天性ミオパチー

臨床試験数 : 10 / 薬物数 : 17 - (DrugBank : 5) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 9

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05099107 (ClinicalTrials.gov)	October 25, 2021	15/10/2021	Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamolas Compa ...	COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled St ...	Congenital Myopathy;Neuromuscular Diseases;Musculoskeletal Diseases;Nemaline Myopathy;Centronuclear ...	Drug: Salbutamol(as Salbutamol Sulfate) 2 Mg Oral Tablet;Drug: SalbutamolOnly Product in Oral Dose F ...	Vastra Gotaland Region	NULL	Enrolling by invitation	6 Years	30 Years	All	20	N/A	Sweden
2	EUCTR2019-001147-51-SE (EUCTR)	31/03/2020	27/09/2019	This is a treatment study for a muscle disorder known as congenital myopathy	Congenital myopathy intervention study - COMPIS	Congenital myopathy MedDRA version: 20.0;Level: PT;Classification code 10062547;Term: Congenital myo ...	Trade Name: Ventoline tablet 2mg INN or Proposed INN: SALBUTAMOL SULFATE Trade Name: Ventoline oral so ...	Västra götalandsregionen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Sweden

First Previous1Next Last